Associate Director
Vir Biotechnology
Associate Director
Vir Biotechnology
Develops monoclonal antibodies for infectious diseases
Vir Biotechnology, Inc. is a clinical-stage biopharmaceutical company focused on powering the immune system to transform lives by discovering and developing medicines for serious infectious diseases and cancer. Its clinical-stage portfolio includes programs for chronic hepatitis delta and multiple PRO-XTEN® dual-masked T-cell engagers across validated targets in solid tumor indications. Vir Biotechnology also has a preclinical portfolio of programs across a range of infectious diseases and oncologic malignancies.
Vir Biotechnology has exclusive rights to the universal PRO-XTEN® masking platform for oncology and infectious disease. PRO-XTEN® is a trademark of Amunix Pharmaceuticals, Inc., a Sanofi company.
We believe the success of our colleagues drives the success of our mission. We are committed to creating a company where everyone feels supported and encouraged to give their best.
THE OPPORTUNITY
Vir Biotechnology is seeking an experienced Temporary Associate Director, Quality Systems (12+ month initial contract) to provide oversight of the company's Quality Management System (QMS) as Vir Bio advances towards regulatory submissions, commercialization readiness, and growth of its development portfolio. This individual will play a critical role in strengthening quality system governance, improving compliance adherence, inspection readiness, and continuous improvement initiatives across the organization.
You will partner closely with cross-functional stakeholders to ensure Quality Systems continue to be phase-appropriate, compliant and aligned with evolving business needs. This role will provide strategic oversight of core Quality Systems processes, drive quality culture initiatives, and support the ongoing maturation of our quality infrastructure in preparation for health authority inspections and commercial operations.
This role is based in our San Francisco, California office with the expectation to be onsite three days per week.
WHAT YOU'LL DO
WHO YOU ARE AND WHAT YOU BRING
WHO WE ARE AND WHAT WE OFFER
The expected hourly range for this position is $80.00 to $109.00 per hour. Actual pay will be determined based on experience, qualifications, geographic location, and other job-related factors.
Applicants must currently be authorized to work for any employer in the U.S. We are unable to sponsor or take over sponsorship of an employment Visa at this time.
All employment decisions at Vir Biotechnology are based on legitimate, non-discriminatory business requirements, job duties and individual qualifications. Employment decisions are made without regard to any legally protected characteristics.
This commitment extends to all management practices and decisions, including recruitment and hiring, compensation, appraisal systems, promotions, training and career development programs. Vir Biotechnology also strongly commits to providing employees with a work environment free of unlawful conduct or harassment.
Vir Biotechnology Human Resources leads recruitment and employment for Vir Biotechnology. Unsolicited resumes sent to the company from recruiters do not constitute any type of relationship between the recruiter and Vir Biotechnology and do not obligate us to pay fees should we hire from those resumes. We ask that external recruiters and/or agencies not contact or present candidates directly to our hiring manager or employees.
For hires based in the United States, Vir Biotechnology, participates in E-Verify.
Develops monoclonal antibodies for infectious diseases
Vir Biotechnology uses the immune system to treat infectious diseases by engineering monoclonal antibodies and exploring T cell vaccines, powered by an AI-assisted antibody discovery platform. Its therapies target diseases with high global impact, including hepatitis B, hepatitis delta, HIV, influenza, COVID-19, RSV/hMPMV, and HPV, with an investigational HIV T cell vaccine in development. Monoclonal antibodies specifically target viral proteins to block infection or mark pathogens for immune attack, while AI helps design and optimize these antibodies. The company differentiates itself through its combination of a proprietary mAb platform, AI/ML-enabled discovery, and broad, collaborative programs to accelerate development. Its goal is to transform lives by delivering therapies that address unmet patient needs and reduce the global burden of infectious diseases.
Explore more opportunities at Vir Biotechnology